Drug Updates

Coding Corner Question: September

Staff | September 1, 2014

Coding for first infliximab infusion in patient with rheumatoid arthritis

Joseph Flood, MD | September 1, 2014

Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

Plus, rheumatology drug news from EULAR 2014

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

James T. Rosenbaum, MD | August 1, 2014

A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions

Joseph Flood, MD | August 1, 2014

The ACR expands advocacy efforts to impact state legislatures, local organizations

Mell Gutarra-Arana, MD; Theniat Haider, MD; Theodore Kieffer, MD; & Steven Hugenberg, MD | August 1, 2014

Diagnosis, treatment and management of AMF in Hispanic patient with lupus

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid